[TARS] QoQ Quarter Result on 30-Jun-2022 [#Q2]

Stock
[TARS] Tarsus Pharmaceuticals, Inc.
Announcement Date
11-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- 69.06%
YoY- -198.69%
Quarter Report
TARS's Result
TARS's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 2,500 10,000 0 15,277 539 338 1,240 59.66%
PBT -23,419 -13,599 -22,516 -5,743 -20,237 -14,797 -16,038 28.73%
Tax -1,533 -521 -5 519 1 54 -341 172.64%
NP -21,886 -13,078 -22,511 -6,262 -20,238 -14,851 -15,697 24.83%
Tax Rate - - - - - - - -
Total Cost 24,386 23,078 22,511 21,539 20,777 15,189 16,937 27.53%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin -875.44 -130.78 0.00 -40.99 -3,754.73 -4,393.79 -1,265.89 -21.81%
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS -0.82 -0.49 -0.84 -0.26 -0.98 -0.72 -0.76 5.20%
EPS Diluted -0.82 -0.49 -0.84 -0.26 -0.98 -0.72 -0.76 5.20%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.